EUVIMEDEUVIMED entdecken
Crossref

Loganin Modulates Sigma‐1 Receptor to Alleviate Depression: Animal, Cellular, and Computational Evidence

Man-Ni Wang, Cong-Yuan Xia, Yu-Xuan Guo, Guo-Yan Zuo, Yung-Chi Cheng, Hua Yang, Wei-Ku Zhang, Jun He, Jie-Kun Xu iD

Phytotherapy Research · 2026-02 · 40 (2) · 375-397

DOI: 10.1002/ptr.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 02.12.2025. Verfasst von Man-Ni Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, sigma, Depression, Antidepressive Agents, Iridoids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National High Level and Elite Medical Professionals Project of China-Japan Friendship Hospital, National Natural Science Foundation of China, Beijing Key Laboratory of Mental Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is known to exacerbate depressive symptoms. Loganin, a major iridoid glycoside derived from Cornus officinalis Sieb. et Zucc., exhibits antidepressant‐like properties and anti‐inflammatory effects; however, the mechanisms underlying these actions remain unclear. Given the involvement of the Sigma‐1 receptor (Sigma‐1R) in both depression and neuroinflammation, this study aimed to investigate whether loganin can ameliorate inflammation‐related depression by modulating Sigma‐1R. Experimental models of social isolation and lipopolysaccharide (LPS)‐induced depressive‐like behaviors were employed. The effects of loganin on behavioral outcomes, neurons, astrocytes, and microglia, oxidative stress levels, and the NLRP3 inflammasome were assessed. Molecular docking analysis and cellular thermal shift assay were conducted to evaluate the binding affinity of loganin to Sigma‐1R. Additionally, the impact of a Sigma‐1R inhibitor (BD1047) on loganin's effects was investigated. Loganin improved social isolation‐ and LPS‐induced depressive‐like behaviors. It also reduced astrocyte and microglia reactivity and decreased oxidative stress levels. Furthermore, loganin downregulated the expression of IRE1α, TXNIP, and the NLRP3 cascade. Molecular docking and cellular thermal shift assays confirmed strong binding of loganin to Sigma‐1R. Loganin increased Sigma‐1R expression in the hippocampus in response to LPS or social isolation. The antidepressant‐like effects of loganin, as well as its inhibition of the NLRP3 inflammasome and oxidative stress, were reversed by BD1047. These findings suggest that loganin alleviates inflammation‐associated depressive‐like behaviors by inhibiting the NLRP3 inflammasome and oxidative stress via the Sigma‐1R/IRE1α/TXNIP pathway, highlighting its potential as a therapeutic agent for inflammation‐related depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, sigmaDepressionAntidepressive AgentsIridoidsSigma-1 ReceptorAnimalsMolecular Docking SimulationNLR Family, Pyrin Domain-Containing 3 ProteinMaleMiceOxidative StressInflammasomesMicrogliaLipopolysaccharidesAstrocytesMice, Inbred C57BLNeurons

Stichwörter der Autor:innen

NLRP3depressionloganinneuroinflammationsigma‐1 receptor

Substanzen

Receptors, sigmaSigma-1 ReceptorAntidepressive AgentsNLR Family, Pyrin Domain-Containing 3 ProteinIridoidsloganinInflammasomesLipopolysaccharides

Autor:innen und Institutionen

  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing, People's Republic of China.
  • School of Medicine, Yale University, New Haven, Connecticut, USA.
  • School of Chemistry and Chemical Engineering, Shaanxi Key Laboratory of Chemical Reaction Engineering, Laboratory of New Energy & New Function Materials, Yan'an University, Yan'an, People's Republic of China.

ORCID-Profile: Jie-Kun Xu

Förderung

  • National High Level and Elite Medical Professionals Project of China-Japan Friendship Hospital
  • National Natural Science Foundation of China
  • Beijing Key Laboratory of Mental Disorders

Zitieren

APA

Wang, M. N., Xia, C. Y., Guo, Y. X., Zuo, G. Y., Cheng, Y. C., Yang, H., Zhang, W. K., He, J., & Xu, J. K. (2026). Loganin Modulates Sigma‐1 Receptor to Alleviate Depression: Animal, Cellular, and Computational Evidence. Phytotherapy Research, 40(2), 375-397. https://doi.org/10.1002/ptr.70141

Vancouver

Wang MN, Xia CY, Guo YX, Zuo GY, Cheng YC, Yang H, et al. Loganin Modulates Sigma‐1 Receptor to Alleviate Depression: Animal, Cellular, and Computational Evidence. Phytotherapy Research. 2026;40(2):375-397. doi:10.1002/ptr.70141

BibTeX
@article{Wang2026,
  author = {Wang, Man-Ni and Xia, Cong-Yuan and Guo, Yu-Xuan and Zuo, Guo-Yan and Cheng, Yung-Chi and Yang, Hua and Zhang, Wei-Ku and He, Jun and Xu, Jie-Kun},
  title = {Loganin Modulates Sigma‐1 Receptor to Alleviate Depression: Animal, Cellular, and Computational Evidence},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {375--397},
  doi = {10.1002/ptr.70141}
}
Kostenlos starten →